PMID: 6989323Apr 1, 1980Paper

Use of Ceporin after a cadaveric kidney allograft

N S BogomolovaL N Vinogradova


Cephaloridin (ceporin of "Pliva", Yugoslavia) was used in the treatment of patients after allotransplantation of the kidney from a cadaver during the early postoperative period with a purpose of prevention (5 patients) and therapy of complications, such as pneumonia (7 patients), sepsis (3 patients), pyelonephritis of the transplanted kidney (4 patients). The drug levels in the blood serum and urine were determined 1, 2, 4, 6, 8 and 24 hours after the administration. The drug was used with regard for the transplant function estimated by the data of the glomerular filtration and concentration of the nitrous residues in the blood. The antibiotic dose depended on the transplant function. The study provided some recommendations as for the ceporin use in therapy of such population of patients.

Related Concepts

Postoperative Procedures
Postoperative Complications
Transplantation, Homologous
Kidney Transplantation

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.